These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23680132)

  • 1. Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.
    Kalman L; Tarleton J; Hitch M; Hegde M; Hjelm N; Berry-Kravis E; Zhou L; Hilbert JE; Luebbe EA; Moxley RT; Toji L
    J Mol Diagn; 2013 Jul; 15(4):518-25. PubMed ID: 23680132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Seifert BA; Reddi HV; Kang BE; Bean LJH; Shealy A; Rose NC;
    Genet Med; 2024 Aug; 26(8):101145. PubMed ID: 38836869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
    Santoro M; Masciullo M; Silvestri G; Novelli G; Botta A
    Clin Genet; 2017 Oct; 92(4):355-364. PubMed ID: 27991661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Jespersen C; Gottesfeld JM
    Hum Mol Genet; 2013 Dec; 22(25):5276-87. PubMed ID: 23933738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of CTG repeats at the DMPK gene in myotonic dystrophy patients and healthy individuals from the Mexican population.
    Magaña JJ; Cortés-Reynosa P; Escobar-Cedillo R; Gómez R; Leyva-García N; Cisneros B
    Mol Biol Rep; 2011 Feb; 38(2):1341-6. PubMed ID: 20635151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
    Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
    Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum LP; Day JW
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical standards and guidelines for myotonic dystrophy type 1 testing.
    Prior TW;
    Genet Med; 2009 Jul; 11(7):552-5. PubMed ID: 19546810
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
    Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triplet-primed PCR is more sensitive than southern blotting-long PCR for the diagnosis of myotonic dystrophy type1.
    Addis M; Serrenti M; Meloni C; Cau M; Melis MA
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1428-31. PubMed ID: 23030650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.
    Ballester-Lopez A; Linares-Pardo I; Koehorst E; Núñez-Manchón J; Pintos-Morell G; Coll-Cantí J; Almendrote M; Lucente G; Arbex A; Magaña JJ; Murillo-Melo NM; Lucia A; Monckton DG; Cumming SA; Ramos-Fransi A; Martínez-Piñeiro A; Nogales-Gadea G
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1.
    Richards CS; Palomaki GE; Hegde M
    Genet Med; 2016 Dec; 18(12):1290-1294. PubMed ID: 27253733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
    Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
    Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMPK-associated myotonic dystrophy and CTG repeats in Alabama African Americans.
    Acton RT; Rivers CA; Watson B; Oh SJ
    Clin Genet; 2007 Nov; 72(5):448-53. PubMed ID: 17877752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.
    Savić D; Rakocvic-Stojanovic V; Keckarevic D; Culjkovic B; Stojkovic O; Mladenovic J; Todorovic S; Apostolski S; Romac S
    Hum Mutat; 2002 Feb; 19(2):131-9. PubMed ID: 11793472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
    Kumar A; Agarwal S; Agarwal D; Phadke SR
    Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved method for molecular diagnosis of myotonic dystrophy type 1 (DM1).
    Erginel-Unaltuna N; Akbas F
    J Clin Lab Anal; 2004; 18(1):50-4. PubMed ID: 14730559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTG expansion & haplotype analysis in DM1 gene in healthy Iranian population.
    Shojasaffar B; Moradin N; Kahrizi K; Cobo AM; Najmabadi H
    Can J Neurol Sci; 2008 May; 35(2):216-9. PubMed ID: 18574937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.